Pacemaker Companies
Pacemakers are critical medical devices that help regulate heart rhythms in individuals with irregular heartbeats or arrhythmias. Several companies specialize in the design, manufacturing, and distribution of pacemakers.
Pacemakers are critical medical devices that help regulate heart rhythms in individuals with irregular heartbeats or arrhythmias. Several companies specialize in the design, manufacturing, and distribution of pacemakers.
Abbott (US) Launched its Aveir DR system in June 2023, the first commercially available dual-chamber leadless pacemaker in the US. This development marks a significant step towards leadless technology becoming mainstream.
Medtronic (US) Received FDA approval for its Micra AV2 dual-chamber leadless pacemaker in May 2023, further expanding its portfolio of leadless technology options.
Boston Scientific (US) Announced plans to launch its EnRhythmâ„¢ MRI conditional dual-chamber leadless pacemaker in Europe in October 2023, aiming to broaden availability of MRI-compatible options.
Livita Medical (Canada) Received CE Mark approval for its S-ICD® subcutaneous defibrillator system in July 2023, offering an alternative to traditional implantable defibrillators for some patients with arrhythmias. This technology may provide a less invasive option for specific cases.
Micropace (US) Announced a strategic partnership with Biotronik (Germany) in August 2023 to collaborate on the development and commercialization of next-generation pacemaker technologies. This collaboration combines expertise for potential future advancements.
List of Pacemaker Key Companies in the Market
Medtronic (Dublin Ireland)
Abbott Laboratories (US)
Boston Scientific (US)
Biotronik (Germany)
Livanova (UK)
Lepu Medical (China)
Shree Pacetronix (India)
Osypka Medical (Germany
Medico Spa (Italy)
Oscor (US)
Pacemaker Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)